Dr. Harry Peery, PhD
Adjunct Assistant Professor
Cumming School of Medicine, Department of Biochemistry and Molecular Biology
Arnie Charbonneau Cancer Institute
Hotchkiss Brain Institute
I came to Canada 33 years ago and have been doing teaching. Writing, and assisting in cancer research across Canada and in the United States ever since. I did my first post-doc at Chalk River (at AECL now Canadian Nuclear Labs) examining the effect of background radiation on a rodent species (deer mouse) that lives near uranium tailings. My second post-doc was at Calgary primarily teaching medical students but also some graduate courses. I began to resume my imaging small tumor research (begun at McMaster) in Karl Riabowol’s lab during this time. I also have written, in collaboration with 3 clinicians at Yale and Hanan Bassyouni, an endocrinologist at Calgary, a textbook in medical endocrinology which includes discussion of endocrine tumors, including several malignant and benign endocrine tumor case studies. The 550-page text was published March 26, 2021 (Elsevier is the publisher). I am also working on an integrated pathology-anatomy-physiology-pharmacology-radiology text with 2 clinicians at New York University, one at the University of Washington and one at the University of Vermont and, as consultants, Chris Naugler in pathology and Director of UME at Calgary and Phillip Xiu at Cambridge in the UK. This text is for medical students and follows Calgary’s approach to medical education. Neoplasia is one of our chapters. It is also published by Elsevier and will be out in 2023. I have also contributed to other medical textbooks. Currently, I have a proposal submitted for a pathophysiology textbook for medicine and biomedical engineering with clinical coauthors at Sidney Kimmel Medical College at Thomas Jefferson University, the University of Indiana, and the University of Washington. I have a second proposal submitted for a clinically oriented undergraduate non-majors biology text for those going into health professions research and/ or practice. I also teach online in graduate programs at the University of Washington in Seattle, and at the Johns Hopkins University in Baltimore, Maryland. I am also an actively licensed registered nurse in Arizona. As my affiliation on these books (and eventually some papers from Karl’s lab), and teaching, it is nice to promote the Arnie Charbonneau Cancer Research Institute.
Areas of Research
- Imaging tumors with a cell mass of less than a million cells
- Effect of INGs on stem cells
I have had an interest in the NMDA receptor for some time and the paraneoplastic neuroautoimmune disorder (NMDA receptor encephalitis) in which it is involved. Am one of the founding directors and the Basic Medical Science Director of The NMDA Receptor Encephalitis Foundation, Inc., headquartered in Ottawa. In this disorder, we cannot see 40% of the tumors that initiate this disorder, largely because they have a cell mass of less than 1 million cells, the limit of resolution of the MRI. I have found two biomarkers that may be useful in finding small tumors in this disorder and in tumor metastasis. Microscopic immunohistochemical confirmation of these biomarkers has been done in Dr. Karl Riabowol's lab, but we need to characterize them biochemically before we publish.
I also have an interest in the ING family of proteins and their effect on stem cell differentiation.
Are you the profile owner?
Login to edit.